AusPAR: Lixisenatide

AusPAR

Attachment: Product Information: Lixisenatide [PDF, 331.74 KB]

Attachment: Product Information: Lixisenatide [Word, 169.94 KB]

Attachment: Extract from Clinical Evaluation Report: Lixisenatide [PDF, 1.88 MB]

Attachment: Extract from Clinical Evaluation Report: Lixisenatide [Word, 2.12 MB]

Device/Product Name

Lyxumia / Lyxumia Treatment initiation pack / Lixisenatide Sanofi / Lixisenatide Sanofi Treatment initiation pack / Lixisenatide Winthrop / Lixisenatide Winthrop Treatment initiation packLyxumia / Lyxumia Treatment initiation pack / Lixisenatide Sanofi / Lixisenatide Sanofi Treatment initiation pack / Lixisenatide Winthrop / Lixisenatide Winthrop Treatment initiation pack

Active ingredients

Lixisenatide

AusPAR Date

20 August 2013

Published

14 October 2013

Submission Number

PM-2011-03163-3-5

Submission Type

New chemical entity

Decision

Approved

Sub menu

AusPAR: Lixisenatide

Help us improve the Therapeutic Goods Administration site